A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently lost in several kinds of tumors, causing uncontrolled https://bookmarksden.com/story22144080/vhh-fragments-reactivate-the-p53-protein-the-potential-pathway-for-malignant-treatment